Race Oncology 2022 Annual Report

26 Aug
Aug , 26 , 2022 Daniel Tillett

LinkedIn

Related posts:

June 2022 Quarterly Activity Report Race Receives Human Ethics Approval for Extramedullary AML & MDS Trial Appointment of Chief Financial Officer